Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126187121 | 12618712 | 1 | I | 20160704 | 20160726 | 20160803 | 20160803 | EXP | FR-GE HEALTHCARE MEDICAL DIAGNOSTICS-OMPQ-PR-1607S-1284 | GE HEALTHCARE | 65.00 | YR | M | Y | 0.00000 | 20160803 | OT | FR | FR |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126187121 | 12618712 | 1 | PS | OMNIPAQUE | IOHEXOL | 1 | Intravenous (not otherwise specified) | 18956 | 185 | ML | SOLUTION FOR INJECTION | ||||||||
126187121 | 12618712 | 2 | SS | OMNIPAQUE | IOHEXOL | 1 | 18956 | ||||||||||||
126187121 | 12618712 | 3 | SS | DIAMOX SEQUELS | ACETAZOLAMIDE | 1 | Oral | 0 | 2.5 | MG | QD | ||||||||
126187121 | 12618712 | 4 | SS | FUROSEMIDE. | FUROSEMIDE | 1 | Oral | 0 | 20 | MG | QD | ||||||||
126187121 | 12618712 | 5 | SS | TICAGRELOR | TICAGRELOR | 1 | Oral | 0 | 90 | MG | QD | ||||||||
126187121 | 12618712 | 6 | SS | LOVENOX | ENOXAPARIN SODIUM | 1 | Subcutaneous | 0 | |||||||||||
126187121 | 12618712 | 7 | SS | AGRASTAT | TIROFIBAN HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | 0 | |||||||||||
126187121 | 12618712 | 8 | SS | BISOPROLOL HEMIFUMARATE | BISOPROLOL FUMARATE | 1 | Oral | 0 | 2.5 | MG | QD | ||||||||
126187121 | 12618712 | 9 | C | RAMIPRIL. | RAMIPRIL | 1 | Oral | 0 | 20 | MG | QD | ||||||||
126187121 | 12618712 | 10 | C | TAHOR | ATORVASTATIN CALCIUM | 1 | Oral | 0 | 80 | MG | QD | ||||||||
126187121 | 12618712 | 11 | C | KARDEGIC | ASPIRIN LYSINE | 1 | Oral | 0 | 75 | MG | QD | ||||||||
126187121 | 12618712 | 12 | C | ASPIRIN. | ASPIRIN | 1 | 0 | ||||||||||||
126187121 | 12618712 | 13 | C | PLAVIX | CLOPIDOGREL BISULFATE | 1 | 0 | ||||||||||||
126187121 | 12618712 | 14 | C | MORPHINE | MORPHINE | 1 | 0 | ||||||||||||
126187121 | 12618712 | 15 | C | PRIMPERAN | METOCLOPRAMIDE HYDROCHLORIDE | 1 | 0 | ||||||||||||
126187121 | 12618712 | 16 | C | PARACETAMOL | ACETAMINOPHEN | 1 | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126187121 | 12618712 | 1 | Myocardial infarction |
126187121 | 12618712 | 2 | Diagnostic procedure |
126187121 | 12618712 | 3 | Myocardial infarction |
126187121 | 12618712 | 4 | Myocardial infarction |
126187121 | 12618712 | 5 | Myocardial infarction |
126187121 | 12618712 | 6 | Chest pain |
126187121 | 12618712 | 9 | Myocardial infarction |
126187121 | 12618712 | 10 | Myocardial infarction |
126187121 | 12618712 | 11 | Myocardial infarction |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126187121 | 12618712 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126187121 | 12618712 | Chills | |
126187121 | 12618712 | Malaise | |
126187121 | 12618712 | Rash maculo-papular |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126187121 | 12618712 | 1 | 20160701 | 20160701 | 0 | |
126187121 | 12618712 | 3 | 20160701 | 20160705 | 0 | |
126187121 | 12618712 | 4 | 20160701 | 20160706 | 0 | |
126187121 | 12618712 | 5 | 20160701 | 0 | ||
126187121 | 12618712 | 6 | 20160630 | 20160630 | 0 | |
126187121 | 12618712 | 7 | 20160702 | 20160702 | 0 | |
126187121 | 12618712 | 8 | 20160701 | 20160705 | 0 | |
126187121 | 12618712 | 9 | 20160701 | 20160706 | 0 | |
126187121 | 12618712 | 10 | 20160701 | 0 | ||
126187121 | 12618712 | 11 | 20160701 | 0 |